News

Olmesartan Delays Microalbuminuria in Type 2


 

From the New England Journal of Medicine

JULIE INGELFINGER, M.D., is deputy editor of the New England Journal of Medicine. She disclosed having received travel/accommodations/meeting expenses from the National Institutes of Health and the Cystinosis Research Foundation. These comments were excerpted from an editorial that accompanied the study (N. Engl. J. Med.2011;384:970-1).

Pages

Recommended Reading

Psoriasis Doubles Risk of Metabolic Syndrome
Type 2 Diabetes ICYMI
Stable Angina Twice as Deadly in Diabetes
Type 2 Diabetes ICYMI
Venular Size May Predict Retinopathy Course
Type 2 Diabetes ICYMI
Pharmacist in Practice Improved Glucose Control
Type 2 Diabetes ICYMI
Diabetes, Depression Raise Mortality in Women
Type 2 Diabetes ICYMI
Bypassing Duodenum Seen to Resolve Diabetes : Improvements in HbA1c, lipids, and insulin were greater with gastric bypass than with restriction.
Type 2 Diabetes ICYMI
Bariatric Surgery Effective in Minorities at 3-Year Follow-Up
Type 2 Diabetes ICYMI
Enterovirus Risk Is 10-Fold Greater in Type 1
Type 2 Diabetes ICYMI
Insulin Regulator Gene Tied to Type 2 Diabetes
Type 2 Diabetes ICYMI
Screening Heart Patients for Diabetes
Type 2 Diabetes ICYMI